Product
GLB-002
1 clinical trial
1 indication
Indication
Non-Hodgkin lymphomaClinical trial
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)Status: Recruiting, Estimated PCD: 2026-01-31